Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tiziana Life Sciences Ltd - Common Shares (NQ:TLSA)

1.300 -0.050 (-3.70%)
Streaming Delayed Price Updated: 11:19 AM EDT, Mar 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tiziana Life Sciences Ltd - Common Shares

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
News headline image
Tiziana Life Sciences Announces Review Article Published in Nature Highlighting Foralumab's Potential in the Treatment of Neurological Disease
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
News headline image
US Stocks Poised To Open Higher As Futures Advance: Tesla, Bumble, Lifecore Bio In Focus ↗
U.S. stock futures were higher on Friday, the slipping in first trading session of 2025. All four index futures advanced in premarket trade. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Tiziana Life Sciences Announces First Patient with Moderate Alzheimer’s Disease Dosed with Intranasal Foralumab
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
News headline image
Tiziana Life Sciences Expands Phase 2 Clinical Trial for Non-Active Secondary Progressive Multiple Sclerosis to Additional Prestigious U.S. Medical Centers
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
News headline image
Elon Musk Says Amazon Founder Jeff Bezos Urged Tesla, SpaceX Investors To Dump Stakes, Predicting Trump's Loss ↗
Tesla Inc (NASDAQ: TLSA) and SpaceX, chief executive officer, Elon Musk sparked a new controversy by saying that Jeff Bezos, the founder and executive chairman of Amazon.com, predicted President-elect... 
Via Benzinga
Topics Government
News headline image
Tiziana Life Sciences Announces Groundbreaking ALS Trial Grant Awarded by the ALS Association
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
News headline image
Cathie Wood Redirects Elon Musk's DOGE Focus Toward Nuclear Energy Amid Regulatory Challenges: Here's How Oklo, Cameco, Centrus Energy And Other Stocks Performed ↗
Nuclear energy stocks and ETFs have come to the fore as ARK Invest's founder Cathie Wood reshared the firm's study on how regulatory hurdles and anti-nuclear sentiment have caused cost overruns and... 
Via Benzinga
Topics ETFs Energy
News headline image
Donald Trump Gives Tesla Wings For 27% Rally Since Presidential Election ↗
The EV giant received a substantial price target hike Monday, suggesting 24% upside. 
Via Investor's Business Daily
Topics Government
News headline image
Tesla Reclaims $1 Trillion Market Cap For First Time Since 2022 In Huge Trump Run ↗
Tesla stock is on pace for its best weekly performance since January 2023. 
Via Investor's Business Daily
Topics Government
News headline image
Tesla Surges To 15-Month High On Election; Musk-Trump Alliance In Focus ↗
Tesla stock is set to hit a 15-month high. 
Via Investor's Business Daily
News headline image
Cathie Wood Sells Tesla Before Election; Musk Cabinet Position "Not What Shareholders Want To See" ↗
Tesla stock flashed a sell signal Monday and is well below a traditional buy point. 
Via Investor's Business Daily
News headline image
Tiziana Life Sciences to Participate in BIO-Europe 2024 to Discuss Recent Clinical Advancements, Including Positive GLP-1 Combination Study Data
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
News headline image
Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $10 Million
Includes initial funding of approximately $5 million, as well as the option for additional proceeds of approximately $5 million 
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
News headline image
Tiziana Life Sciences Announces Positive Results from Ozempic and Nasal Anti-CD3 Combination Study
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
Elon Musk May Unveil Tesla's Robotaxi, But Consumers Respond With 'Ehhh,' New Study Reveals Skepticism, Need For Trust-Building ↗
Consumer support for robotaxis is low for people who have not been inside a self-driving vehicle or live in a city where the vehicles operate. 
Via Benzinga
News headline image
Tiziana Life Sciences Announces $4 Million Grant Awarded by National Institutes of Health to Study Anti-CD3 in Alzheimer’s Disease
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
News headline image
Tiziana Life Sciences Appoints New Chief Executive Officer
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
News headline image
Tiziana Life Sciences Regains Compliance with Nasdaq Listing Minimum Bid Price Rule
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
News headline image
The 3 Best EV Stocks to Buy in August 2024 ↗
The best EV stocks may face an uphill battle, but their share prices seem too depressed after the latest plunge. 
Via InvestorPlace
News headline image
Tiziana Life Sciences Granted FDA Fast Track Designation
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
News headline image
Tiziana Receives $3.4 Million in Non-Dilutive Funding
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
News headline image
Tiziana Life Sciences adds to treasury with $3.4 million in non-dilutive funding
Tiziana Life Sciences adds to treasury with $3.4 million in non-dilutive funding 
Via News Direct
News headline image
Tiziana Life Sciences to Dose First Patient with Moderate Alzheimer’s Disease with Foralumab
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
FDA Accepts Tiziana Life Sciences Fast Track Designation Submission for Treatment of Multiple Sclerosis
From Tiziana Life Sciences Ltd.
Via GlobeNewswire
News headline image
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises
EQNX::TICKER_START (NASDAQ:TLSA),(NYSE:LLY),(OTCQX:RHHBY),(NASDAQ:BIIB),(NASDAQ:TGTX) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises
From FN Media Group LLC
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.